News & Events

Latest News

5/9/2013

UC Cancer Institute Announces Program Leaders, Core Disease-Based Centers

UC Cancer Institute Announces Program Leaders, Core Disease-Based Centers The University of Cincinnati Cancer Institute is moving forward, with a strategic plan built around comprehensive, disease-based centers of excellence and an appointed leadership team to guide the overall institute's efforts.

5/1/2013

Espay Directing Movement Disorders Symposium May 15

Alberto Espay, MD, associate professor of neurology and rehabilitation medicine, will direct the Unusual Movement Disorders Marathon Symposium held from 5 to 10 p.m. Wednesday, May 15, at the Cincinnati Club, 30 Garfield Place, downtown.

4/4/2013

HEALTH LINE: Symposium Benefits Brain Aneurysm Survivors and Caregivers

Recovery from a brain aneurysm can be a long, difficult process, fraught with misunderstanding and frustration on the part of survivors and caregivers alike. That's why events such as the annual Brain Aneurysm Symposium scheduled for this month on the University of Cincinnati medical campus are important to both groups.

3/13/2013

UC Announces John M. Tew, Jr., MD, Chair in Neurosurgical Oncology

The University of Cincinnati today announced the inauguration of the John M. Tew, Jr., MD, Chair in Neurosurgical Oncology, a $2 million endowment at the UC College of Medicine.

2/28/2013

HEALTH LINE: Optimal Timing of Deep Brain Stimulation for Parkinson's Gets Fresh Look

For more than 15 years, deep brain stimulation (DBS) surgery has been an important treatment option for people with Parkinson's disease, a disorder of the nervous system caused by a lack of dopamine in the brain. Now, a European study is causing doctors to ask whether the procedure should be offered earlier in the disease process.

2/8/2013

Research Shows How Delay in Breaking up Clots Translates to Worse Stroke Outcome

Every 30-minute delay in breaking up a blood clot from a stroke was associated with a 10-percent decrease in the probability of a good outcome, regardless of other factors such as stroke severity, according to new research led by a University of Cincinnati neurologist.

2/7/2013

Combination Therapy for Acute Ischemic Stroke Is Safe and Warrants Larger Study, Researchers Find

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide is safe and warrants a larger study to demonstrate it improves outcome after acute ischemic stroke, a study led by University of Cincinnati researchers has found.

2/7/2013

UC Researchers Help Quantify Benefits of Active Treatment With Clot-Busting Drug After Bleeding Stroke

Research led by the University of Cincinnati Neuroscience Institute and Johns Hopkins University has found that minimally invasive delivery of the drug tPA directly into potentially lethal blood clots in the brain helped more patients function independently a year after suffering an intracerebral hemorrhage, a deadly and debilitating form of stroke.

Subscribe

More Information

Media Contact:

Cindy Starr, MSJ
Communications Department
513-558-3505
cindy.starr@uc.edu